ACKERMAN JOEL — SEC insider filings
SEC reporting owner CIK 1220630. 40 insider filings on record with FilingPulse; latest filed 2026-11-09.
Transaction summary — filings shown
Covers all 40 filings on record, filed 2020-11-03 to 2026-11-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 158,000 shares, $25,511,045 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 92.
- Largest priced transaction: sale of 64,029 shares @ $155.06 ($9,928,586) in DAVITA INC., filed 2024-08-29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| DAVITA INC. (DVA) | CFO and Treasurer | 27 | — | 4 legs · 158,000 sh · $25,511,045 | 68 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | Director | 13 | — | — | 24 |
Insider filings — ACKERMAN JOEL
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-09 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 31,216 (derivative) @ $4.76 | EDGAR |
| 2026-10-16 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 69,794 @ $1.60 · Option exercise (M): 69,794 (derivative) @ $1.60 | EDGAR |
| 2026-05-11 | 4 | DAVITA INC. (DVA) | Sale (S): 51,471 @ $192.10 | EDGAR |
| 2026-03-17 | 4 | DAVITA INC. (DVA) | Grant/award (A): 5,706 @ $0 · Tax withholding (F): 3,362 @ $150.72 · Tax withholding (F): 33,693 @ $150.72 · Tax withholding (F): 5,765 @ $150.72 · Grant/award (A): 15,427 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | DAVITA INC. (DVA) | Grant/award (A): 6,585 @ $0 · Grant/award (A): 65,997 @ $0 | EDGAR |
| 2026-02-09 | 4 | DAVITA INC. (DVA) | Option exercise (M): 44,065 @ $108.93 · Disposition to issuer (D): 32,168 @ $149.22 · Tax withholding (F): 5,100 @ $149.22 · Option exercise (M): 44,065 (derivative) @ $0 | EDGAR |
| 2025-11-07 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 21,216 (derivative) @ $6.80 | EDGAR |
| 2025-11-06 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 94,405 @ $2.10 · Option exercise (M): 94,405 (derivative) @ $2.10 | EDGAR |
| 2025-03-18 | 4 | DAVITA INC. (DVA) | Grant/award (A): 5,995 @ $0 · Tax withholding (F): 3,093 @ $143.45 · Tax withholding (F): 3,331 @ $143.45 · Grant/award (A): 16,597 (derivative) @ $0 | EDGAR |
| 2025-03-14 | 4 | DAVITA INC. (DVA) | Grant/award (A): 7,394 @ $0 · Grant/award (A): 7,221 @ $0 | EDGAR |
| 2024-11-18 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 43,190 (derivative) @ $4.64 | EDGAR |
| 2024-11-01 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 88,470 @ $2.10 · Option exercise (M): 16,667 @ $5.43 · Option exercise (M): 88,470 (derivative) @ $2.10 · Option exercise (M): 16,667 (derivative) @ $5.43 | EDGAR |
| 2024-09-17 | 4 | DAVITA INC. (DVA) | Option exercise (M): 78,999 @ $75.95 · Disposition to issuer (D): 36,684 @ $163.56 · Tax withholding (F): 21,602 @ $163.56 · Option exercise (M): 78,999 (derivative) @ $0 | EDGAR |
| 2024-08-29 | 4 | DAVITA INC. (DVA) | Sale (S): 64,029 @ $155.06 · Sale (S): 4,740 @ $155.02 | EDGAR |
| 2024-03-18 | 4 | DAVITA INC. (DVA) | Grant/award (A): 14,349 @ $0 · Grant/award (A): 1,445 @ $0 · Grant/award (A): 10,977 @ $0 · Tax withholding (F): 8,064 @ $136 | EDGAR |
| 2024-03-08 | 4 | DAVITA INC. (DVA) | Option exercise (M): 55,000 @ $52.41 · Disposition to issuer (D): 21,408 @ $134.65 · Tax withholding (F): 17,149 @ $134.65 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | DAVITA INC. (DVA) | Option exercise (M): 55,000 @ $52.41 · Disposition to issuer (D): 23,436 @ $123 · Tax withholding (F): 14,930 @ $123 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2024-01-05 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 114,552 @ $2.10 · Option exercise (M): 100,000 (derivative) @ $2.10 · Option exercise (M): 14,552 (derivative) @ $2.10 | EDGAR |
| 2023-11-07 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 35,750 (derivative) @ $5.51 | EDGAR |
| 2023-08-17 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 26,500 (derivative) @ $7 | EDGAR |
| 2023-05-17 | 4 | DAVITA INC. (DVA) | Tax withholding (F): 7,625 @ $96.86 · Tax withholding (F): 12,861 @ $96.86 | EDGAR |
| 2023-05-12 | 4 | DAVITA INC. (DVA) | Option exercise (M): 56,306 @ $66.29 · Disposition to issuer (D): 37,059 @ $100.72 · Tax withholding (F): 9,826 @ $100.72 · Option exercise (M): 56,306 (derivative) @ $0 | EDGAR |
| 2023-04-06 | 4 | DAVITA INC. (DVA) | Grant/award (A): 2,790 @ $0 | EDGAR |
| 2023-03-17 | 4 | DAVITA INC. (DVA) | Grant/award (A): 23,672 @ $0 · Tax withholding (F): 4,260 @ $76.04 · Tax withholding (F): 709 @ $76.04 | EDGAR |
| 2023-03-13 | 4 | DAVITA INC. (DVA) | Grant/award (A): 1,387 @ $0 | EDGAR |
| 2023-02-27 | 4 | DAVITA INC. (DVA) | Grant/award (A): 22,400 @ $0 · Grant/award (A): 8,343 @ $0 | EDGAR |
| 2022-10-20 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 16,667 @ $3.21 · Option exercise (M): 16,667 (derivative) @ $0 | EDGAR |
| 2022-05-17 | 4 | DAVITA INC. (DVA) | Tax withholding (F): 9,414 @ $100.05 · Tax withholding (F): 2,875 @ $100.05 · Tax withholding (F): 14,082 @ $100.05 · Tax withholding (F): 7,624 @ $100.05 | EDGAR |
| 2022-04-21 | 4 | DAVITA INC. (DVA) | Grant/award (A): 18,438 @ $0 · Grant/award (A): 28,385 @ $0 | EDGAR |
| 2022-03-17 | 4 | DAVITA INC. (DVA) | Grant/award (A): 43,388 (derivative) @ $0 | EDGAR |
| 2021-11-09 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 18,564 (derivative) @ $10.10 | EDGAR |
| 2021-08-11 | 4 | DAVITA INC. (DVA) | Option exercise (M): 145,159 @ $68.89 · Disposition to issuer (D): 75,093 @ $133.17 · Tax withholding (F): 37,226 @ $133.17 · Option exercise (M): 145,159 (derivative) @ $0 | EDGAR |
| 2021-08-06 | 4 | DAVITA INC. (DVA) | Sale (S): 37,760 @ $131.36 | EDGAR |
| 2021-05-18 | 4 | DAVITA INC. (DVA) | Tax withholding (F): 712 @ $125.41 · Tax withholding (F): 11,180 @ $125.41 · Tax withholding (F): 2,756 @ $125.41 · Tax withholding (F): 1,419 @ $125.41 · Tax withholding (F): 8,272 @ $125.41 | EDGAR |
| 2021-04-21 | 4 | DAVITA INC. (DVA) | Grant/award (A): 1,456 @ $0 · Grant/award (A): 2,899 @ $0 | EDGAR |
| 2021-03-17 | 4 | DAVITA INC. (DVA) | Grant/award (A): 44,065 (derivative) @ $0 | EDGAR |
| 2021-03-01 | 4 | DAVITA INC. (DVA) | Grant/award (A): 22,832 @ $0 · Grant/award (A): 16,894 @ $0 | EDGAR |
| 2020-12-21 | 4 | DAVITA INC. (DVA) | Tax withholding (F): 4,890 @ $115.36 | EDGAR |
| 2020-12-10 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Grant/award (A): 16,667 (derivative) @ $11.96 | EDGAR |
| 2020-11-03 | 4 | CHAMPIONS ONCOLOGY, INC. (CSBR) | Option exercise (M): 124,232 @ $5.76 · Option exercise (M): 2,708 @ $4.80 · Option exercise (M): 124,232 (derivative) @ $5.76 · Option exercise (M): 2,708 (derivative) @ $4.80 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1220630 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs